We are live on ! Find out more
EDSA icon

Edesa Biotech

10 hedge funds and large institutions have $81K invested in Edesa Biotech in 2020 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

710% more capital invested

Capital invested by funds: $10K → $81K (+$71K)

25% more funds holding

Funds holding: 810 (+2)

0.02% more ownership

Funds ownership: 0.01%0.03% (+0.02%)

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

Holders
10
Holders Change
+2
Holders Change %
+25%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
2
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
CS
1
Credit Suisse
Switzerland
$49K +$32.2K +1,429 New
UBS Group
2
UBS Group
Switzerland
$16K +$6.96K +309 +209%
BBA
3
Braun-Bostich & Associates
Pennsylvania
$15K
Osaic Holdings
4
Osaic Holdings
Arizona
$1K -$23 -1 -5%
Bank of America
5
Bank of America
North Carolina
-$991 -44 -96%
CFD
6
Creative Financial Designs
Indiana
+$68 +3 New

EDSA Hedge Fund Activity: Q2 2020 in Review

10 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q2 2020, worth a combined $81K — up 710% from $10K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new EDSA positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 2 trimmed.

The largest buyer was Credit Suisse, opening a new position worth an estimated $32.2K. The largest seller was Bank of America, cutting an estimated $991.

  • 10 institutional investors held Edesa Biotech (EDSA) as of Q2 2020, up from 8 in Q1 2020.
  • Funds reported $81K of Edesa Biotech stock for Q2 2020, up 710% quarter-over-quarter.
  • 2 funds opened new Edesa Biotech positions in Q2 2020 and 0 closed out, a net change of +2 holders.
  • The largest Edesa Biotech buyer in Q2 2020 was Credit Suisse, an estimated $32.2K added.
  • The largest Edesa Biotech seller in Q2 2020 was Bank of America, an estimated $991 sold.

Based on aggregated 13F filings for Q2 2020.